This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Lg Life Sciences, Limited. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Jun Jung - Innovator in Hybrid Promoter Technology
Introduction
Jun Jung is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of hybrid promoters for enhancing protein expression in eukaryotic cells. His work is crucial for advancements in pharmaceutical applications, including antibody development and DNA vaccine production.
Latest Patents
Jun Jung holds a patent for a "Hybrid promoter and recombinant vector comprising the same." This invention relates to a hybrid promoter that combines elements from a CMV enhancer, a β-actin promoter, a CMV promoter, and a β-actin intron. The innovative design allows for high expression levels of target proteins in eukaryotic cells, making it a valuable tool for researchers and developers in the biotechnology sector.
Career Highlights
Jun Jung is currently employed at LG Life Sciences, Limited, where he continues to work on innovative solutions in the life sciences industry. His expertise in genetic engineering and molecular biology has positioned him as a key player in his field.
Collaborations
He collaborates with talented colleagues, including Yeon Chul Kim and Saem Jung, to further enhance the impact of their research and development efforts.
Conclusion
Jun Jung's contributions to hybrid promoter technology exemplify the importance of innovation in biotechnology. His work not only advances scientific understanding but also paves the way for new therapeutic developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile